Product Profile of Blisto Mf 1 & 2

Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. They present blisto mf 1 & 2.

• Composition of blisto 1mf-glimepiride 1 mg + metformin 500 mg tablets and blisto 2mf- glimepiride 2 mg + metformin 1000 mg tablets

• In the treatment of type ii diabetes mellitus

• Used when one anti-diabetes drug fails to control blood Glucose level